IMATINIB MESYLATE 400 mg/1

Imatinib Mesylate 400 mg is a prescription medication used to treat certain types of cancer. This oral tablet is manufactured by Camber Pharmaceuticals, Inc. in the USA.

Imatinib Mesylate is primarily used in the treatment of specific types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by targeting certain proteins in cancer cells to help slow or stop their growth. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Common effects of Imatinib Mesylate may include nausea, vomiting, diarrhea, muscle cramps, and swelling. Some users may also experience fatigue, skin rash, or mild stomach pain. It is important to discuss any persistent or severe side effects with a healthcare professional.

Imatinib Mesylate should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients with liver or kidney problems should inform their doctor before starting this medication.

Imatinib Mesylate may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional.